# End-of-Phase 2A Meetings - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/end-of-phase-2a-meetings/05202b67-ba5f-49de-b49a-1f5466adf224

> FDA guidance document: End-of-Phase 2A Meetings. Issue date: September 18, 2009. Get complete insights and analysis.

---

## Details

- Title: End-of-Phase 2A Meetings
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2009-09-18
- Last Changed: 2020-05-01
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0514">FDA-2008-D-0514</a>

## Related Documents

- [Individual Product Bioequivalence Recommendations for Specific Products](https://www.globalkeysolutions.net/guidances/guidance-document/individual-product-bioequivalence-recommendations-for-specific-products/321fabfb-8008-4b1d-856f-9a2e7d5e26b1)
- [Residual Solvents in Drug Products Marketed in the United States:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/residual-solvents-in-drug-products-marketed-in-the-united-states-guidance-for-industry/2d91b105-6b2c-4231-bcff-63a0d7fdc832)
- [Time and Extent Applications for Nonprescription Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/time-and-extent-applications-for-nonprescription-drug-products/08491a11-f749-4a9d-82fc-6a6d13776eb7)